Ifenprodil

Ifenprodil
Clinical data
Trade namesCerocral, Dilvax, Vadilex
Other namesNP-120; NP 120; NP120; RC 61-91
Drug classCerebral vasodilators; NMDA receptor antagonists
ATC code
Identifiers
  • 4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.041.341
Chemical and physical data
FormulaC21H27NO2
Molar mass325.452 g·mol−1
3D model (JSmol)
  • CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
  • InChI=1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3 Y
  • Key:UYNVMODNBIQBMV-UHFFFAOYSA-N Y
  (verify)

Ifenprodil, sold under the brand names Cerocral, Dilvax, and Vadilex, is a cerebral vasodilator that has been marketed in some countries, including in Japan, Hong Kong, and France. It is currently under development for treatment of a variety of additional indications.

Ifenprodil has multiple known pharmacological actions. It is an inhibitor of the NMDA receptor, specifically of NMDA receptors containing GluN1 and GluN2B subunits, the "ifenprodil binding site". Additionally, ifenprodil inhibits GIRK channels and interacts with α1-adrenergic, serotonin, and sigma receptors.

Chemically, ifenprodil is a substituted phenethylamine and β-hydroxyamphetamine derivative. It is used pharmaceutically as the tartrate salt.